Furthermore, the ICI treatment was reported to result in immune activation in the TME, for example, enhanced CD8+ T cell infiltration [4,19,36], which could induce HLA class I expression on tumor cells in response to increased lymphocyte cytokine production. Here, CD8A is linked to neoplasm.